Viewing Study NCT02035605


Ignite Creation Date: 2025-12-25 @ 3:29 AM
Ignite Modification Date: 2026-03-01 @ 1:44 PM
Study NCT ID: NCT02035605
Status: COMPLETED
Last Update Posted: 2020-12-19
First Post: 2014-01-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Study of an Investigational Drug, ALN-AT3SC, in Healthy Volunteers and Hemophilia A or B Patients
Sponsor: Sanofi
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hemophilia A View
None Hemophilia B View
Keywords: